A recent study also demonstrated the expression of PCNA on the cell surface of triple-negative breast cancer cells (TNBCs), which interact with NK cell receptors through NKp44, leading to the inhibition of the NK cell cytolysis function against cancer cells. This evidence concerns the gene PCNA and cancer.